Peripheral Candidal Suppurative Thrombophlebitis Successfully Treated with Caspofungin in a Bariatric Surgery Patient

Peripheral Candidal Suppurative Thrombophlebitis Successfully Treated with Caspofungin in a Bariatric Surgery Patient

Bibliographic Details
Main Authors:	Özgür GÜNAL, Şener BARUT, Ayhan KAYAOĞLU, Ayfer ATAY
Format:	Article
Language:	Turkish
Published:	Galenos Yayinevi 2012-12-01
Series:	Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:	Candida thrombophlebitis caspofungin
Online Access:	http://www.mjima.org/pdf.php?&id=5

Similar Items

Biofilm-associated candidal thrombophlebitis
by: Shinnosuke Fukushima, et al.
Published: (2023-01-01)

Caspofungin in Recurrent Fluconazole Resistant Candida Esophagitis Treatment
by: Çiğdem EROL, et al.
Published: (2007-09-01)

Susceptibility to caspofungin is regulated by temperature and is dependent on calcineurin in Candida albicans
by: Lijun Zheng, et al.
Published: (2023-12-01)

Disseminated candidemia refractory to caspofungin therapy in an infant with extremely low birth weight
by: Meng-Ju Li, et al.
Published: (2012-01-01)

Great saphenous vein suppurative thrombophlebitis due to Fusobacterium necrophorum infection
by: Abduallah Mawkili
Published: (2022-01-01)

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
by: Gerardo Becerra Victorio, et al.

Management of a case of Candida albicans endogenous endophthalmitis with intravitreal caspofungin
by: Harshali Manish Yadav, et al.
Published: (2017-01-01)

The Utilization Pattern of Caspofungin in an Educational Hospital
by: Soodeh Ramezaninejad, et al.
Published: (2019-12-01)

Susceptibility Pattern of Caspofungin-Coated Gold Nanoparticles Against Clinically Important Candida Species
by: Zahra Salehi, et al.
Published: (2021-09-01)

Proteomic Analysis of Caspofungin-Induced Responses in Planktonic Cells and Biofilms of Candida albicans
by: Peng Li, et al.
Published: (2021-02-01)

Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach
by: Giuseppe Buda De Cesare, et al.
Published: (2022-12-01)

Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics
by: C Sanz-Rodriguez, et al.
Published: (2005-11-01)

In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method
by: Qianting Yang, et al.
Published: (2022-09-01)

Caspofungin-induced β(1,3)-glucan exposure in Candida albicans is driven by increased chitin levels
by: Andrew S. Wagner, et al.
Published: (2023-08-01)

The Effects of Holothurin and Caspofungin on the Vaginal Cell Inflammation Parameters of the Rattus norvegicus Strain Post Induction of Candida albicans
by: Handayani S, et al.
Published: (2023-04-01)

Catheter-related gas-forming suppurative thrombophlebitis
by: Yasuyoshi Miyamura, et al.
Published: (2024-03-01)

Cellular apoptosis: An alternative mechanism of action for caspofungin against Candida glabrata
by: Parisa Aryamloo, et al.
Published: (2019-06-01)

Management of Catheter Induced Upper Limb Suppurative Thrombophlebitis in a Patient after Coronary Artery Bypass Graft Surgery: a Case Report
by: Shahriar Mali, et al.
Published: (2020-06-01)

Drug susceptibility pattern of candida species isolated from skin of neonates to fluconazole, amphotericin B and caspofungin
by: Soraya Ghorbani, et al.
Published: (2017-07-01)

Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association
by: Andrea Duminuco, et al.
Published: (2021-11-01)

Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia
by: Roya Sattarzadeh Badkoubeh, et al.
Published: (2022-08-01)

Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species
by: Roberta Fais, et al.
Published: (2022-08-01)

Routine Offered Protocol is not reliable for Thrombophlebitis Prevention
by: Habib Yaribeygi, et al.
Published: (2016-05-01)

Tactics of treatment of the inflow varico-thrombophlebitis
by: S. S. Filip, et al.
Published: (2020-10-01)

Peripheral Intravenous Catheter related Thrombophlebitis- Incidence and Risk Factors A Cross Sectional Study
by: Zohaib Jamal, et al.
Published: (2019-02-01)

Treatment of Pneumocystis jirovecii Pneumonia with Caspofungin and Clindamycin: An HIV Patient and Literature Review
by: Gül Ruhsar YILMAZ, et al.
Published: (2024-03-01)

The study of the pharmacological activity of thick extract from the leaves of Corylus avellana on the model of peripheral vascular thrombophlebitis in rabbit ear
by: L. M. Maloshtan, et al.
Published: (2017-04-01)

Immune thrombocytopenia and cerebral thrombophlebitis in a patient on eltrombopag: A rare complication
by: Salma Fares, MD, et al.
Published: (2023-06-01)

Deep Septic Pelvic Thrombophlebitis – a Life-Threatening Condition in Postpartum Period
by: Srgeja Kozar, et al.
Published: (2021-01-01)

Thrombophlebitis of the external jugular vein: A variant of Lemierre’s syndrome
by: Yasuhiro Suzuki, et al.
Published: (2021-01-01)

Pelvic Thrombophlebitis: a Case Report of a 34-Year-Old Woman with Klebsiella Positive Blood Culture
by: Sahar Babaali, et al.
Published: (2017-10-01)

Antifungal Susceptibility of Oral <i>Candida</i> Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin
by: Naemah Alkhars, et al.
Published: (2023-05-01)

Inferior mesenteric vein thrombophlebitis secondary to acute diverticulitis
by: Andrew Waack, BS, et al.
Published: (2023-05-01)

Acute osteomyelitis, thrombophlebitis, and pulmonary embolism: a case report
by: Mohammad Sheikh Najeeb, et al.
Published: (2023-10-01)

Superficial thrombophlebitis (Mondor′s Disease) after breast augmentation surgery
by: P. Viana Giovanni Andre, et al.
Published: (2008-07-01)

Septic pelvic thrombophlebitis of unknown origin: an ever threatening entity
by: Roberta Muriel Longo Roepke, et al.
Published: (2014-09-01)

A Markerless CRISPR-Mediated System for Genome Editing in Candida auris Reveals a Conserved Role for Cas5 in the Caspofungin Response
by: Craig L. Ennis, et al.
Published: (2021-12-01)

Are Systemic Voriconazole and Caspofungin Ototoxic? An Experimental Study with Rats
by: Emine Aydın, et al.
Published: (2012-09-01)

Outcomes of caspofungin use in the treatment of Candida-related urinary tract infections, a case series
by: Laila Rkieh, et al.
Published: (2022-01-01)

<i>Candida albicans</i> Strains Adapted to Caspofungin Due to Aneuploidy Become Highly Tolerant under Continued Drug Pressure
by: Farha Husain, et al.
Published: (2022-12-01)